The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular Atrophy.

Edinoff, Amber N; Nguyen, Long H; Odisho, Amira S; Maxey, Benjamin S; Pruitt, John W; Girma, Brook; Cornett, Elyse M; Kaye, Adam M; Kaye, Alan D

Edinoff, Amber N; Nguyen, Long H; Odisho, Amira S; Maxey, Benjamin S; Pruitt, John W; Girma, Brook; Cornett, Elyse M; Kaye, Adam M; Kaye, Alan D.

Afiliación

Edinoff AN; Louisiana State University Health Science Center Shreveport.
Nguyen LH; Louisiana State University Health Science Center Shreveport.
Odisho AS; Louisiana State University Health Science Center Shreveport.
Maxey BS; Louisiana State University Health Science Center Shreveport.
Pruitt JW; Louisiana State University Health Science Center Shreveport.
Girma B; Louisiana State University Health Science Center Shreveport.
Cornett EM; Louisiana State University Health Science Center Shreveport.
Kaye AM; Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific.
Kaye AD; Louisiana State University Health Science Center Shreveport.

Orthop Rev (Pavia) ; 13(2): 24934, 2021.

Article en En | MEDLINE | ID: mdl-34745470

Palabras clave

antisense oligonucleotide; nusinersen; smn1; spinal muscular atrophy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Orthop Rev (Pavia) Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google